Surgery Partners Sees $22 Price Target From Mizuho Amid Mixed Analyst Ratings
On November 17, 2025, Mizuho Securities initiated a price target of $22 for Surgery Partners, Inc. (NASDAQ:SGRY), projecting a potential upside of 44.74% from a trading price of $15.20. The healthcare services company's stock later closed at $15.06, a decrease of 1.47% or $0.22 for the day. The stock traded between $15.01 and $15.57 during the session.
The new price target comes amid a significant increase in options market activity for the company. Traders acquired 6,122 put options, representing a 498% increase compared to the daily average volume of 1,024 contracts. This heightened activity in put options can suggest hedging or bearish sentiment from some market participants.
Analyst ratings for Surgery Partners remain varied. Cantor Fitzgerald holds an overweight rating with a $36 price target, and the Royal Bank of Canada maintains an outperform rating with a $31 target. More recently, Benchmark adjusted its price target downward from $35 to $30, although it sustained a buy rating. In contrast, Weiss Ratings has reaffirmed a sell (d-) rating for the stock.
Surgery Partners operates a network of surgical facilities across the United States. The company has a market capitalization of approximately $1.95 billion. The stock has recorded a 52-week high of $26.16 and a 52-week low of $15.01.
Surgery Partners, Inc. (SGRY) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.